The initial excitement surrounding ivermectin began when scientists observed that it reduced SARS-CoV-2 viral replication in cultured cells. However, the high doses used in the study did not translate well to humans. An examination of several small clinical studies found that ivermectin showed some benefit, however the quality of the studies in the analysis has been called into question. Dr. Seheult presents a hypothesis whereby ivermectin may benefit COVID-19 patients in parts of the world prone to clinically silent parasitic infections. Upon hospital admission, dexamethasone — administered to suppress an overactive immune system — may allow dormant parasitic infections to become active. Because ivermectin is an antiparasitic agent, it may benefit these patients not for its role against SARS-CoV-2, but by killing parasites. In this clip, Dr. Roger Seheult describes ivermectin and its possible role against COVID-19.

Watch the full episode here:    • COVID Vaccine Myths, Questions, and R...  

Subscribe to FoundMyFitness:    / @foundmyfitness  

Subscribe to MedCram:    / @medcram  

Original episode posted Sep 17, 2021.
#Ivermectin #mRNAvaccine #spikeprotein